Business Description
Veru Inc. is a Miami-based biopharmaceutical company focused on developing treatments for metabolic conditions, cancer, and severe respiratory illness caused by viral infections. Its product portfolio includes the FC2 female condom, which protects against both unintended pregnancy and sexually transmitted infections, as well as several drugs in late-stage clinical trials targeting obesity-related muscle loss, metastatic breast cancer, and life-threatening lung complications in hospitalized patients. Originally founded in 1971 as The Female Health Company, the business adopted its current name in 2017.
